Direct transactivation of the anti-apoptotic gene apolipoprotein J (clusterin) by B-MYB
about
Interleukin-6 affects cell death escaping mechanisms acting on Bax-Ku70-Clusterin interactions in human colon cancer progressionEffects of B-Myb on gene transcription: phosphorylation-dependent activity ans acetylation by p300E6AP gene suppression and characterization with in vitro selected hammerhead ribozymes.Clusterin expression in normal mucosa and colorectal cancer.Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer.Expression profiles of acute lymphoblastic and myeloblastic leukemias with ALL-1 rearrangementsB-Myb, cancer, senescence, and microRNAs.The tumour-suppressive function of CLU is explained by its localisation and interaction with HSP60.Effects of female sex hormones on clusterin expression and paclitaxel resistance in endometrial cancer cell linesAddiction of MYCN amplified tumours to B-MYB underscores a reciprocal regulatory loopMYBL2 is an independent prognostic marker that has tumor-promoting functions in colorectal cancer.Antisense approaches in prostate cancer.Stem cell pluripotency: a cellular trait that depends on transcription factors, chromatin state and a checkpoint deficient cell cycle.Clusterin expression can be modulated by changes in TCF1-mediated Wnt signaling.Antisense therapy for cancer.Regulation of CLU gene expression by oncogenes and epigenetic factors implications for tumorigenesis.Antisense oligodeoxynucleotide therapy targeting clusterin gene for prostate cancer: Vancouver experience from discovery to clinic.Interplay of nuclear factor-kappaB and B-myb in the negative regulation of androgen receptor expression by tumor necrosis factor alphaThe potential of clusterin inhibiting antisense oligodeoxynucleotide therapy for prostate cancer.Anticlusterin treatment of breast cancer cells increases the sensitivities of chemotherapy and tamoxifen and counteracts the inhibitory action of dexamethasone on chemotherapy-induced cytotoxicity.Clusterin, a haploinsufficient tumor suppressor gene in neuroblastomas.Clusterin and chemoresistance.Clusterin, a gene enriched in intestinal stem cells, is required for L1-mediated colon cancer metastasis.A transcriptional regulatory element in the coding sequence of the human Bcl-2 gene.MYBL2 (B-Myb): a central regulator of cell proliferation, cell survival and differentiation involved in tumorigenesis.Assessment of citalopram and escitalopram on neuroblastoma cell lines. Cell toxicity and gene modulation.Knockdown of clusterin expression increases the in vitro sensitivity of human prostate cancer cells to paclitaxel.Clusterin as a therapeutic target.Clusterin and chemotherapy sensitivity under normoxic and graded hypoxic conditions in colorectal cancer.Disruption of B-myb in DT40 cells reveals novel function for B-Myb in the response to DNA-damage.Delayed activation of insulin-like growth factor-1 receptor/Src/MAPK/Egr-1 signaling regulates clusterin expression, a pro-survival factor.B-Myb acts as a repressor of human COL1A1 collagen gene expression by interacting with Sp1 and CBF factors in scleroderma fibroblastsExpression of insulin-like growth factor-binding protein 5 in neuroblastoma cells is regulated at the transcriptional level by c-Myb and B-Myb via direct and indirect mechanisms.PARP co-activates B-MYB through enhanced phosphorylation at cyclin/cdk2 sites.Patients with Congenital Limb Anomaly Show Short Telomere, Shutdown of Telomerase and Deregulated Expression of Various Telomere-Associated Proteins in Peripheral Blood Mononuclear Cells-A Case Series.Apolipoprotein-J prevents angiotensin II-induced apoptosis in neonatal rat ventricular cells.Essential requirement of apolipoprotein J (clusterin) signaling for IkappaB expression and regulation of NF-kappaB activity.Temperature-dependent modification and activation of B-MYB: implications for cell survival.
P2860
Q24596148-4E401F39-C583-416E-9B16-4CA014F8830CQ28208710-DA7DF57E-5751-4BC3-A30A-73594CD85B94Q30732777-EA653FFD-7D21-4D24-A871-FC459BEDF445Q33275487-A7619CFE-16E6-4591-BBF7-C59191C782F3Q34453304-73CDF91F-0C3B-49D2-ACC5-EC465BEA441BQ35147070-6E7B7A99-9641-49D8-B505-C31A13A05508Q35164933-EA74D944-C658-401C-9AFF-6572BB6A5CA6Q35558587-76432D58-E1CE-43D5-AD52-8D5AEC9E1D4EQ35632043-B7933794-8BC6-42F7-A86F-FF5BC00E3D66Q35640074-AE59C115-FF72-4607-9CCF-8E23CC0482ACQ35758028-ED580AAB-C4F7-42FE-A404-73BCFD9F6BF4Q35790875-BACBA866-3969-4918-97DE-11A297E29332Q35889873-AF650F7B-C78A-4F51-AE97-3BB8124AAD4EQ35991157-F74A8D70-DEC0-42CF-9D9F-6BDE426D9716Q36133133-1331F2FE-E14B-44CF-A26A-28A811CA47B8Q36184999-63789D60-8B39-426B-96F8-E14361B39365Q36275522-0CED2868-20A1-4A54-8CFA-B98FD6AD9074Q36447432-06CB32B6-1759-4BFC-A0A1-68FCB889F9C7Q36458374-07E189D6-53DA-4974-99E9-07EAB658458AQ36465338-856C66FD-DA05-46F8-96BC-CB1231E24A4EQ37288916-25640701-EC94-4D2C-93DC-CBBAB18C55D2Q37625188-1030D0B0-D231-4DE6-96C5-1EED8FB6C986Q38259980-FF17D703-882C-47CB-B129-75A3C7D52C44Q38332936-BF1D55FB-433B-4AE2-B290-36A9C08EE166Q38668036-9A9D3F32-25E2-4246-83DC-56625D48263FQ38705079-58CAD7EB-C8E6-4C7C-98B3-00455581E2E7Q38945355-D77DFF73-5A09-43A0-AA32-4600DC6155EAQ39039324-ACE9EBCE-2C39-4F47-8701-BCE87AE7F59FQ39559518-1B34A07C-908E-4EAF-B49B-792ED9F86F23Q40371705-259431A9-B234-4F6D-815A-528054FC9E2DQ40462263-39D37596-8666-4991-85F2-B2172E68EC4EQ40617050-8076F7FE-B91D-4625-B3F3-44D59F6CB214Q40735954-371DCF6A-2728-42CF-900B-134FB6ED94B9Q40758269-65829D43-C81D-4B81-8813-DD17976872E2Q41918206-B1973ED9-3690-447B-8F96-1E54D6598D2FQ42230369-B85AC8A8-2CE3-4066-B3A3-0FA0CD2014A1Q52551428-FD7F4595-27C3-4290-9D74-A0CC860FFD4BQ52561894-246D4893-9F1F-41FA-ADD8-540567DCCB9F
P2860
Direct transactivation of the anti-apoptotic gene apolipoprotein J (clusterin) by B-MYB
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Direct transactivation of the anti-apoptotic gene apolipoprotein J (clusterin) by B-MYB
@ast
Direct transactivation of the anti-apoptotic gene apolipoprotein J (clusterin) by B-MYB
@en
Direct transactivation of the anti-apoptotic gene apolipoprotein J (clusterin) by B-MYB
@en-gb
Direct transactivation of the anti-apoptotic gene apolipoprotein J (clusterin) by B-MYB
@nl
type
label
Direct transactivation of the anti-apoptotic gene apolipoprotein J (clusterin) by B-MYB
@ast
Direct transactivation of the anti-apoptotic gene apolipoprotein J (clusterin) by B-MYB
@en
Direct transactivation of the anti-apoptotic gene apolipoprotein J (clusterin) by B-MYB
@en-gb
Direct transactivation of the anti-apoptotic gene apolipoprotein J (clusterin) by B-MYB
@nl
prefLabel
Direct transactivation of the anti-apoptotic gene apolipoprotein J (clusterin) by B-MYB
@ast
Direct transactivation of the anti-apoptotic gene apolipoprotein J (clusterin) by B-MYB
@en
Direct transactivation of the anti-apoptotic gene apolipoprotein J (clusterin) by B-MYB
@en-gb
Direct transactivation of the anti-apoptotic gene apolipoprotein J (clusterin) by B-MYB
@nl
P2093
P2860
P921
P356
P1476
Direct transactivation of the anti-apoptotic gene apolipoprotein J (clusterin) by B-MYB
@en
P2093
B Calabretta
C Sevignani
G Raschella
G Santilli
M Cervellera
P2860
P304
P356
10.1074/JBC.M002055200
P407
P577
2000-07-14T00:00:00Z